iQ-MS

This AI-based iQ (intelligent Quantitation) software future proofs clinical and research radiology reporting with accurate, reproducible measurement of brain tissue and brain pathology across a range of neurological diseases:

Detection of disease progression, even before symptomatic worsening, is key to delivering precision care and preventing neurological disability:

 

 

iQ-MS – Next generation lesion activity assessment: 

  1. Quantitative, precise, lesion assessment [existing (red), new (blue), enlarging (green) lesions]

  2. Lesion number, volume and change from prior study.

SNAC’s iQ-MS™ produces real-time, customisable reports to monitor the changes in lesions and brain volume changes, including:

  • Measurement of FLAIR white matter hyperintensities (WMH) and contrast-enhancing T1 hyperintensities.

  • Comparison between present scan and previous timepoint to measure brain volume changes, WMH changes, and changes in thalamus.

  • Volumetric comparison to healthy cohort and patient cohort to display a more precise disease progression stage.

 

iQ-solutions Interpretation​
  • 1. Patient Information Table
  • 2. 3-axis display for quick QA of Segmentations
  • 3. Cross-Sectional Metrics
  • 4. Longitudinal Metrics
  • 5. Normative Plots Metric